Billionaires Holding GALT

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 22.1M
    Shares Outstanding

  • 44.92M
    Market Cap

News & Insights

ABOUT

GALT

Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrat...

Here’s Buffett’s Most Recent Acquisition

NEWS

Herbalife: Carl Icahn Comes Out On Top

READ MORE